Zobrazeno 1 - 10
of 128
pro vyhledávání: '"Maher Albitar"'
Autor:
Tatyana Feldman, Maher Albitar, Hong Cheng, Kar Chow, Alessandra Petrillo, Ahmetmursel Ulusan, Andrew Ip, Alexandra Della Pia, Gabriella Magarelli, Brittany Lukasik, Lori Leslie, Pritish K. Bhattacharyya, Andrew L. Pecora, Andre H. Goy
Publikováno v:
Blood. 140:11893-11895
Autor:
Maher Albitar, Andrew Ip, Andre H. Goy, Katherine Linder, Jeffrey Justin Estella, Ahmad Charifa, Wanlong Ma, Andrew L. Pecora, Jamie Koprivnikar, James McCloskey
Publikováno v:
Blood. 140:6270-6271
Autor:
Maher Albitar, Hong Zhang, Andrew Ip, Jeffrey Justin Estella, Ahmad Charifa, Wanlong Ma, Ipsa Sharma, Andrew L. Pecora, Lori Leslie, Tatyana Feldman, Andre H. Goy
Publikováno v:
Blood. 140:7828-7829
Autor:
Maher Albitar, Hong Zhang, Andrew L. Pecora, Andrew Ip, Andre H. Goy, Spiraggelos Antzoulatos, Wanlong Ma, Sukhdeep Kaur, Hyung C. Suh, Michele L. Donato, Scott D. Rowley
Publikováno v:
Blood. 140:4757-4758
Autor:
Ruba Shalhoub, Neal S. Young, Fernanda Gutierrez-Rodrigues, Katherine R. Calvo, Ma Evette Barranta, Xing Fan, Ronan Desmond, Stephanie Sellers, Bogdan Dumitriu, Thomas Winkler, Colin O. Wu, Danielle M. Townsley, Janet Valdez, David J. Young, Maher Albitar, Jennifer Lotter, Cynthia E. Dunbar
Publikováno v:
Blood Advances. 4:1700-1710
There is no standard or widely effective treatment of patients with moderate aplastic anemia (MAA) or hypo-productive uni-lineage cytopenias (UC). Eltrombopag (EPAG), a small molecule thrombopoietin mimetic, has previously been shown to result in dur
Autor:
Dennis D. Hickstein, Cynthia E. Dunbar, So Gun Hong, Thomas Winkler, Shiqin J. Yu, Danielle M. Townsley, Sergio A. Hassan, Elaine Kang, Xavi Guitart, Jizhong Zou, Vinh Dang, Stefan Cordes, Flavia S. Donaires, Steven M. Holland, Moonjung Jung, Maher Albitar, Amy P. Hsu
Publikováno v:
Blood Advances. 2:3553-3565
GATA2 deficiency is an inherited or sporadic genetic disorder characterized by distinct cellular deficiency, bone marrow failure, various infections, lymphedema, pulmonary alveolar proteinosis, and predisposition to myeloid malignancies resulting fro
Autor:
Farhad Ravandi, Koichi Takahashi, Feng Wang, Keyur P. Patel, Elias Jabbour, Steven M. Kornblau, Guillermo Garcia-Manero, Rashmi Kanagal-Shamanna, Zeev Estrov, Guillermo Montalban-Bravo, Rajyalakshmi Luthra, Sanam Loghavi, Jairo Matthews, Hagop M. Kantarjian, Maher Albitar, Nicholas J. Short, Ghayas C. Issa, Rita Assi, Miguel Franquiz, Wanlong Ma
Circulating cell-free DNA (ccfDNA) allows for noninvasive peripheral blood sampling of cancer-associated mutations and has established clinical utility in several solid tumors. We performed targeted next-generation sequencing of ccfDNA and bone marro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cb5a8d33bfea7e3e586e727e5ccd155
https://europepmc.org/articles/PMC7189293/
https://europepmc.org/articles/PMC7189293/
Autor:
Andre Goy, Hong Zhang, Andrew Ip, Ivan De Dios, Jeffrey Estella, Tatyana Feldman, Andrew L. Pecora, Maher Albitar, Wanlong Ma, Lori A. Leslie
Publikováno v:
Blood. 138:4480-4480
Introduction: Liquid biopsy has been reported to be useful in predicting residual disease in patients with diffuse large B-cell lymphoma (DLBCL). Most of the studies focused on quantifying the level of circulating lymphoma-specific DNA. We explored t
Autor:
Andrew Ip, Andre Goy, Scott D. Rowley, Hong Zhang, Andrew L. Pecora, Ivan De Dios, Hyung C. Suh, Sukhdeep Kaur, Michele L. Donato, Wanlong Ma, Maher Albitar, Spiraggelos Antzoulatos
Publikováno v:
Blood. 138:2892-2892
Introduction: Acute graft-vs.-host disease (aGVHD) remains a major diagnostic and clinical problem in patients after allogenic hematopoietic stem cell transplant (HSCT). Finding biomarkers that play a role in aGVHD not only helps in predicting and di
Autor:
Andrew Ip, Ivan De Dios, Sukhdeep Kaur, Hyung C. Suh, Andre Goy, Scott D. Rowley, Jeffrey Estella, Andrew L. Pecora, Maher Albitar, Michele L. Donato, Hong Zhang, Wanlong Ma
Publikováno v:
Blood. 138:1828-1828
Introduction: Using next generation sequencing (NGS) in monitoring residual disease in patients with myeloid neoplasms is complicated by the significant heterogeneity in these diseases and the frequent presence of CHIP (clonal hematopoiesis of indete